Insider: Cloonan Michael President & CEO - Sionna Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 547,343 | 0 | 547,343 |
| Value | $22,594,319.04 | $0.00 | $22,594,319.04 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 10/21/2025 | DDS | 13,324 | Direct | COM | $34.44 | $458,878.56 | 547,343 |
| 10/21/2025 | DDS | 30,049 | Direct | COM | $35.63 | $1,070,645.87 | 547,343 |
| 10/21/2025 | DDS | 22,895 | Direct | COM | $36.60 | $837,957.00 | 547,343 |
| 10/21/2025 | DDS | 33,532 | Direct | COM | $37.31 | $1,251,078.92 | 547,343 |
| 10/16/2025 | DDS | 10,225 | Direct | COM | $31.46 | $321,690.77 | 547,343 |
| 10/16/2025 | DDS | 200 | Direct | COM | $34.00 | $6,800.00 | 547,343 |
| 10/15/2025 | DDS | 14,775 | Direct | COM | $31.11 | $459,662.07 | 547,343 |
| 09/29/2025 | DDS | 7,793 | Direct | COM | $29.70 | $231,451.32 | 547,343 |
| 09/26/2025 | DDS | 17,207 | Direct | COM | $28.85 | $496,346.24 | 547,343 |
| 08/27/2025 | DDS | 7,426 | Direct | COM | $25.01 | $185,713.86 | 547,343 |
| 08/26/2025 | DDS | 17,574 | Direct | COM | $24.96 | $438,647.04 | 547,343 |
| 08/20/2025 | DDS | 25,000 | Direct | COM | $22.75 | $568,750.00 | 547,343 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research